AKT1 and colitis: Based on our RNA-seq analysis results, mice with DSS-induced colitis treated with low-dose IL-2 exhibited the differential expression of a specific set of genes in the colon, in particular, those associated with the PI3K-AKT signaling pathway—compared to mice treated with PBS (Figure 5).